Cyclooxygenase 2 inhibition in patients with non–small cell lung cancer: Is this still a valid target for therapy?

Author： Gadgeel Shirish M.  

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|121|18|3197-3200

ISSN： 0008-543X

Source： Cancer, Vol.121, Iss.18, 2015-09, pp. : 3197-3200

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selective Cyclooxygenase-2 Inhibitors and Non-small Cell Lung Cancer

By  

Current Medicinal Chemistry, Vol. 9, Iss. 21, 2002-11 ,pp. : 1851-1858

Bentham Science Publishers

Access to resources Recommend Favorite

Cryoablation Combined with Molecular Target Therapy Improves the Curative Effect in Patients with Advanced Non-small Cell Lung Cancer

By Gu XY   Jiang Z   Fang W  

The Journal of International Medical Research, Vol. 39, Iss. 5, 2011-09 ,pp. : 1736-1743

Field House Publishing

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor Receptor as Target for Advanced Non-Small Cell Lung Cancer Therapy

By  

Current Drug Targets, Vol. 11, Iss. 7, 2010-07 ,pp. : 865-874

Bentham Science Publishers

Access to resources Recommend Favorite

Non-small cell lung cancer: from targeted therapy to tailored therapy

By Malgieri Simona   Feliciano Salvatore   Bosso Davide   Federico Piera   Palmieri Giovannella   De Placido Sabino   Di Lorenzo Giuseppe   Buonerba Carlo  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 13, 2012-09 ,pp. : 1817-1819

Informa Healthcare

Access to resources Recommend Favorite

Non–Small Cell Lung Cancer

By  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 3, 2008-03 ,pp. : 228-228

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite